Smith+Nephew reports director's shareholding
A PDMR transaction has been disclosed in compliance with regulations.
See the latest news and media coverage for Smith+Nephew. We track all announcements, press releases, and industry mentions in real time, all in one place.
Portfolio medical technology company for tissue repair and replacement
smith-nephew.comLast updated
In short: Smith+Nephew reported a 15.5% jump in 2025 profit, launched its new RISE strategy, and acquired Integrity Orthopaedics for up to $450 million.
A PDMR transaction has been disclosed in compliance with regulations.
It shows growth across all units and regions, innovation-driven growth, unchanged guidance, and $500 million share buyback.
The China facility receives recognition for operational excellence.
Invests $296m in innovation. Shares 170-year history and new RISE strategy in annual report.
Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.
Smith & Nephew PLC (LSE:SN) efforts to expand its surgical robotics platform and strengthen its orthopaedics pipeline received a vote of confidence from surgeons at...
Subsequent changes in holdings or intentions must be reported in amended filings. This material is...
Six months ago, Deepak Nath unveiled his second three-year plan as CEO of Smith & Nephew, the UK-listed medical supplies group that makes replacement hips...
Track Smith+Nephew and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Smith+Nephew and other trending companies.